AR228468A1 - Procedimiento para la preparacion de nuevas imidazolil-fenilamidinas - Google Patents

Procedimiento para la preparacion de nuevas imidazolil-fenilamidinas

Info

Publication number
AR228468A1
AR228468A1 AR287608A AR28760881A AR228468A1 AR 228468 A1 AR228468 A1 AR 228468A1 AR 287608 A AR287608 A AR 287608A AR 28760881 A AR28760881 A AR 28760881A AR 228468 A1 AR228468 A1 AR 228468A1
Authority
AR
Argentina
Prior art keywords
phenylamidines
procedure
preparation
new imidazolyl
imidazolyl
Prior art date
Application number
AR287608A
Other languages
English (en)
Spanish (es)
Original Assignee
Angeli Inst Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angeli Inst Spa filed Critical Angeli Inst Spa
Application granted granted Critical
Publication of AR228468A1 publication Critical patent/AR228468A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AR287608A 1980-11-28 1981-11-27 Procedimiento para la preparacion de nuevas imidazolil-fenilamidinas AR228468A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8026323A IT1209431B (it) 1980-11-28 1980-11-28 Imidazolilfenil amidine, processi per la loro preparazione e loro impiego farmaceutico, ed intermedi di preparazione.

Publications (1)

Publication Number Publication Date
AR228468A1 true AR228468A1 (es) 1983-03-15

Family

ID=11219229

Family Applications (1)

Application Number Title Priority Date Filing Date
AR287608A AR228468A1 (es) 1980-11-28 1981-11-27 Procedimiento para la preparacion de nuevas imidazolil-fenilamidinas

Country Status (30)

Country Link
US (2) US4386099A (cs)
EP (1) EP0053407B1 (cs)
JP (1) JPS57120575A (cs)
KR (1) KR880001317B1 (cs)
AR (1) AR228468A1 (cs)
AT (1) ATE24495T1 (cs)
AU (1) AU554592B2 (cs)
CA (1) CA1171092A (cs)
CS (2) CS249544B2 (cs)
DD (1) DD201893A5 (cs)
DE (2) DE3175754D1 (cs)
DK (1) DK157862C (cs)
ES (6) ES8207151A1 (cs)
FI (1) FI73209C (cs)
GB (1) GB2088375B (cs)
GR (1) GR77310B (cs)
HK (1) HK88186A (cs)
HU (1) HU187478B (cs)
IE (1) IE51946B1 (cs)
IL (1) IL64388A (cs)
IT (1) IT1209431B (cs)
MY (1) MY8700146A (cs)
NO (1) NO158183C (cs)
NZ (1) NZ199093A (cs)
PH (2) PH17390A (cs)
PL (2) PL135749B1 (cs)
PT (1) PT74048B (cs)
SU (2) SU1110381A3 (cs)
YU (2) YU42447B (cs)
ZA (1) ZA818240B (cs)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1200371B (it) * 1982-03-24 1989-01-18 Angeli Inst Spa Guanidino eterociclifenilamidine,processi per la loro preparazione e loro impiego farmaceutico
IT1201523B (it) * 1982-05-18 1989-02-02 Angeli Inst Spa Eterociclilfenilfomramidine,processi per la loro preparazione e loro uso farmaceutico
IT1210914B (it) * 1982-07-29 1989-09-29 Angeli Inst Spa Eterociclilfenilsolfonil e fosfonilamidine sostituite, procedimento per la loro preparazione e loro uso farmaceutico.
IT1206498B (it) * 1983-07-18 1989-04-27 Angeli Inst Spa Derivati amidinici del4-fenilmidazolo 2-sostituto processi per la loro preparazione e loro uso farmaceutico.
IT1204910B (it) * 1987-01-28 1989-03-10 Angeli Inst Spa Composizioni farmaceutiche ad azione sinergica antisecretoria per la cicatrizzazione dell'ulcera gastroduodenale
KR920004935B1 (ko) * 1990-07-12 1992-06-22 일양약품공업 주식회사 N-디메톡시 페닐알킬-n'-이미다졸릴페닐 아미딘 유도체 및 그의 제조방법
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
TW460460B (en) 1997-11-04 2001-10-21 Chugai Pharmaceutical Co Ltd Heterocyclic compounds having NOS inhibitory activities
CN1250209C (zh) * 1999-11-01 2006-04-12 大正制药株式会社 20-羟基二十碳四烯酸合成酶抑制剂
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US20080045575A1 (en) * 2004-12-29 2008-02-21 Van Dyke Thomas E Delivery of H2 Antagonists
WO2007031513A1 (en) * 2005-09-13 2007-03-22 Bayer Cropscience Ag Pesticide thiazolyloxy substituted phenylamidine derivatives
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
EP2825159B1 (en) 2012-03-15 2022-06-22 Boehringer Ingelheim Vetmedica GmbH Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
MX2016000727A (es) 2013-07-19 2016-04-13 Boehringer Ingelheim Vetmed Composicion farmaceutica acuosa liquida que contiene derivados de ciclodextrina eterificada con conservante.
HUE056143T2 (hu) 2013-12-04 2024-01-28 Boehringer Ingelheim Vetmedica Gmbh Pimobendán javított gyógyászati készítményei
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069340A (en) * 1976-01-30 1978-01-17 Hooker Chemicals & Plastics Corporation Immonium salts and derivatives thereof
DE2645477C2 (de) * 1976-10-08 1982-03-04 Dynamit Nobel Ag, 5210 Troisdorf Verfahren zur Herstellung von Orthoessigsäurealkylestern
US4225724A (en) * 1977-01-07 1980-09-30 Westwood Pharmaceuticals, Inc. 1-(2-Phenylureylene)imidazoles
US4236015A (en) * 1977-01-07 1980-11-25 Westwood Pharmaceuticals, Inc. 1-(2-Acylaminophenyl)imidazoles
US4160097A (en) * 1977-01-07 1979-07-03 Westwind Pharmaceuticals, Inc. 1-(2-Phenylureylene)imidazoles

Also Published As

Publication number Publication date
ATE24495T1 (de) 1987-01-15
GB2088375B (en) 1985-01-09
JPH0233031B2 (cs) 1990-07-25
PL234007A1 (en) 1983-03-14
MY8700146A (en) 1987-12-31
SU1110382A3 (ru) 1984-08-23
ES507508A0 (es) 1982-09-01
ES507509A0 (es) 1982-09-01
IE812790L (en) 1982-05-28
ES507501A0 (es) 1982-09-01
IL64388A (en) 1985-04-30
GB2088375A (en) 1982-06-09
CS249544B2 (en) 1987-03-12
AU7794781A (en) 1982-06-03
NZ199093A (en) 1985-05-31
IT1209431B (it) 1989-07-16
EP0053407A3 (en) 1983-07-27
ZA818240B (en) 1983-07-27
PT74048B (en) 1983-12-07
EP0053407A2 (en) 1982-06-09
ES8207148A1 (es) 1982-09-01
FI73209B (fi) 1987-05-29
YU175983A (en) 1984-06-30
US4465841A (en) 1984-08-14
YU278081A (en) 1984-06-30
ES8207150A1 (es) 1982-09-01
YU42878B (en) 1988-12-31
DD201893A5 (de) 1983-08-17
IE51946B1 (en) 1987-04-29
PL136015B1 (en) 1986-01-31
KR880001317B1 (ko) 1988-07-23
ES8207151A1 (es) 1982-09-01
GR77310B (cs) 1984-09-11
DE53407T1 (de) 1983-01-20
PT74048A (en) 1981-12-01
US4386099A (en) 1983-05-31
DK157862B (da) 1990-02-26
YU42447B (en) 1988-08-31
IT8026323A0 (it) 1980-11-28
ES8207152A1 (es) 1982-09-01
DK525581A (da) 1982-05-29
ES8207149A1 (es) 1982-09-01
PH17390A (en) 1984-08-08
NO158183C (no) 1988-07-27
PL238422A1 (en) 1983-06-06
PH19032A (en) 1985-12-06
KR830007575A (ko) 1983-11-04
FI73209C (fi) 1987-09-10
CA1171092A (en) 1984-07-17
ES8207147A1 (es) 1982-09-01
NO814065L (no) 1982-06-01
AU554592B2 (en) 1986-08-28
IL64388A0 (en) 1982-02-28
JPS57120575A (en) 1982-07-27
NO158183B (no) 1988-04-18
DE3175754D1 (en) 1987-02-05
HU187478B (en) 1986-01-28
EP0053407B1 (en) 1986-12-30
HK88186A (en) 1986-11-28
PL135749B1 (en) 1985-12-31
ES507506A0 (es) 1982-09-01
DK157862C (da) 1990-08-06
ES507505A0 (es) 1982-09-01
SU1110381A3 (ru) 1984-08-23
FI813794L (fi) 1982-05-29
ES507507A0 (es) 1982-09-01
CS249115B2 (en) 1987-03-12

Similar Documents

Publication Publication Date Title
MX6869E (es) Procedimiento para la preparacion de dibenzimidiazoazepinas
MX6802E (es) Procedimiento para la preparacion de derivados carboestirilicos
ES502546A0 (es) Procedimiento para la preparacion de nuevas n-ariloxazolidi-nonas-2
AR228468A1 (es) Procedimiento para la preparacion de nuevas imidazolil-fenilamidinas
AR226202A1 (es) Procedimiento para la preparacion de 7-acil-3-yodometil-cefalosporinas
MX160977A (es) Procedimiento para la preparacion de cloroformiatos alfa-clorados
ES507635A0 (es) Procedimiento para la preparacion de nuevas fenilalcohilaminas .
AR227906A1 (es) Procedimiento para la preparacion de derivados de 1-fenil-2-ciclohexen-1-alquilamina
ES501535A0 (es) Procedimiento para la preparacion de derivados de alquilfos-fonito
ES501464A0 (es) Procedimiento para la preparacion de nuevas fenilureas
ES503407A0 (es) Procedimiento para la preparacion de derivados de pirimidina
ES499729A0 (es) Procedimiento para la preparacion de derivados de fenoxi- aminopropanol
ES526538A0 (es) Procedimiento para la preparacion de nuevas tienobenzodiazepinonas sustituidas
ES502212A0 (es) Procedimiento para la preparacion de n-di-n-propil-2,6-dini-tro-4-trifluorometilanilina
ES503975A0 (es) Procedimiento para la preparacion de nuevas fenilureas
ES502120A0 (es) Procedimiento para la preparacion de compuestos de viniles- tilbeno
ES501736A0 (es) Procedimiento para la preparacion de derivados de 2-guanidi-notiazol
ES500068A0 (es) Procedimiento para la obtencion de nuevos tioles
ES502649A0 (es) Procedimiento para la preparacion de derivados de fenoxi- aminopropanol substituidos
ES500071A0 (es) Procedimiento para la preparacion de nuevos 2-nitro-5-feno- xifenil-oxazoles,-oxacinas,-imidazoles,-pirimidinas o-tiazo-les
ES505576A0 (es) Procedimiento para la preparacion de derivados de 7-oxopros-taciclina
MX6707E (es) Procedimiento para la preparacion de n(1-alil-2-pirrolidinilmetil)-2-metoxi-4-amino-5-metil-sulfamoil-benzamida
AR229350A1 (es) Procedimiento para la preparacion de nuevas guanilamidinas
ES505095A0 (es) Procedimiento para la preparacion de nuevas pirazinas
ES499356A0 (es) Procedimiento para la preparacion de derivados de rifamicina